Surge in Cannabis-Related ER Visits Sparks Calls for THC Regulation
Canada sees a surge in ER visits from marijuana users with CHS, prompting calls for THC regulation. Stay updated on cannabis industry impacts.
The rise in cannabis hyperemesis syndrome cases underscores the need for clearer guidelines on THC levels in cannabis products, impacting both public health and the cannabis industry's regulatory framework. This development is crucial for consumers, healthcare providers, and investors in the cannabis sector, highlighting the importance of informed usage and the potential for regulatory changes that could affect market dynamics.
